Cue Biopharma Inc (CUE)

Jun 14, 2025

Millennium Management LLC Reduces Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 14, 2025

Jun 13, 2025

Bank of America Corp DE Acquires 85,113 Shares of Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 13, 2025

Jun 10, 2025

CueBiopharma (CUE) Appoints Interim CFO as Kerri-Ann Millar Resi - GuruFocus

Jun 10, 2025

Jun 10, 2025

Cue Biopharma CFO Kerri-Ann Millar to Depart - marketscreener.com

Jun 10, 2025

Jun 10, 2025

Cue Biopharma CFO Resignation and Board Appointment - TipRanks

Jun 10, 2025

Jun 10, 2025

Cue Biopharma CEO Daniel Passeri To Serve As Interim CFO - marketscreener.com

Jun 10, 2025

Jun 09, 2025

Jane Street Group LLC Has $70,000 Stock Holdings in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 09, 2025

Jun 05, 2025

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com

Jun 05, 2025

Jun 03, 2025

Cue Biopharma, Inc. (NASDAQ:CUE) Shares Purchased by Northern Trust Corp - Defense World

Jun 03, 2025

May 16, 2025

Stifel Financial Corp Grows Stock Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 16, 2025

May 15, 2025

Transcript : Cue Biopharma, Inc.Special Call - marketscreener.com

May 15, 2025

May 14, 2025

Cue Biopharma Inc Reports Q1 2025 Earnings: EPS of -$0.17 Misses Estimate, Revenue Falls Short at $0.4 Million - GuruFocus

May 14, 2025

May 14, 2025

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025

May 13, 2025

Cue Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025

May 13, 2025

Cue Biopharma (CUE) Reports Revenue Miss for Q1 2025 | CUE Stock News - GuruFocus

May 13, 2025

May 12, 2025

Cue Biopharma Reports Strategic Collaboration with Boehringer Ingelheim and Financial Results for Q1 2025 - Nasdaq

May 12, 2025

May 08, 2025

Cue Biopharma (CUE) Schedules Virtual Investor Event to Showcase Biologics Platform | CUE Stock News - GuruFocus

May 08, 2025

May 08, 2025

Cue Biopharma to Host Virtual Investor Event on May 15, 2025 - The Manila Times

May 08, 2025

May 05, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Li - GuruFocus

May 05, 2025

May 05, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference - The Manila Times

May 05, 2025

May 05, 2025

Cue Biopharma Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

May 05, 2025

May 02, 2025

Geode Capital Management LLC Grows Stake in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 02, 2025

May 02, 2025

LPL Financial LLC Has $47,000 Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 02, 2025

May 01, 2025

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

May 01, 2025

Apr 24, 2025

CUECue Biopharma Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 21, 2025

Cue Biopharma stock holds $2 target, Market Outperform rating - Investing.com Australia

Apr 21, 2025

Apr 21, 2025

Cue Biopharma stock holds $2 target, Market Outperform rating By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 17, 2025

Petri Dish: Roche unloads drug to Cambridge biotech, Cue and Boehringer link up - The Business Journals

Apr 17, 2025

Apr 16, 2025

Cue Biopharma stock falls after pricing capital raise of $20M via securities offering - MSN

Apr 16, 2025

Apr 16, 2025

Cue Biopharma Inc Announces $20 Million Public Offering Amidst C - GuruFocus

Apr 16, 2025

Apr 16, 2025

Boehringer and Cue Biopharma to develop autoimmune therapies - Pharmaceutical Technology

Apr 16, 2025

Apr 16, 2025

Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune,... - Medical Dialogues

Apr 16, 2025

Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 15, 2025

Apr 15, 2025

Cue Biopharma (CUE) Partners with Boehringer Ingelheim to Advance B Cell Therapy | CUE Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Boehringer’s bispecific pact with Cue Biopharma; HepaRegeniX raises €21.5M - Endpoints News

Apr 15, 2025

Apr 15, 2025

Cue Biopharma Rises On Partnership With Boehringer To Develop CUE-501 For Autoimmune Diseases - Nasdaq

Apr 15, 2025

Apr 15, 2025

Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases - Contract Pharma

Apr 15, 2025

Apr 15, 2025

Boehringer Ingelheim and Cue Biopharma agree to advance CUE-501 for autoimmune diseases - BioWorld MedTech

Apr 15, 2025

Apr 15, 2025

Cue stock in focus after pact with Boehringer (CUE:NASDAQ) - Seeking Alpha

Apr 15, 2025

Apr 15, 2025

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases - Lelezard

Apr 15, 2025

Apr 15, 2025

Boehringer and Cue Biopharma partner to develop next-generation treatments - The Pharma Letter

Apr 15, 2025

Apr 15, 2025

Cue Biopharma stock holds $2 target, JMP reiterates rating By Investing.com - Investing.com India

Apr 15, 2025

Apr 15, 2025

Cue Biopharma stock holds $2 target, JMP reiterates rating - Investing.com Australia

Apr 15, 2025

Apr 15, 2025

Cue Biopharma (CUE) Launches Public Offering of Common Stock and Warrants | CUE Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Cue Biopharma to Host Business Update Call and Webcast | CUE Sto - GuruFocus

Apr 15, 2025

Apr 15, 2025

Cue Biopharma Prices $20 Million Public Offering of Stock, Warrants - marketscreener.com

Apr 15, 2025